Effect of the Dietary Supplement SAMe on Blood Homocysteine Levels
1 other identifier
interventional
52
1 country
1
Brief Summary
The purpose of this study is to determine if the oral intake of the dietary supplement SAMe increases blood homocysteine levels in healthy human subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2005
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2005
CompletedFirst Submitted
Initial submission to the registry
January 30, 2006
CompletedFirst Posted
Study publicly available on registry
January 31, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2006
CompletedJanuary 6, 2012
January 1, 2012
10 months
January 30, 2006
January 4, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Homocysteine levels pre- and post- one month of SAMe administration.
1 Month
Secondary Outcomes (1)
An interim (2 week) homocysteine level, high sensitivity C-reactive protein (hsCRP) level, lipid studies, and liver blood tests.
2 Weeks
Study Arms (2)
SAMe
ACTIVE COMPARATORTwo 400 mg pills.
Placebo
PLACEBO COMPARATORTwo placebo pills (identical in appearance to SAMe).
Interventions
Eligibility Criteria
You may qualify if:
- Women and men age 18 - 65
- Able to understand and sign a consent form
You may not qualify if:
- Smoking
- Pregnant or lactating
- Women actively trying to conceive
- Diagnosis of panic disorder or bipolar disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55905, United States
Related Publications (1)
Thompson MA, Bauer BA, Loehrer LL, Cha SS, Mandrekar JN, Sood A, Wahner-Roedler DL. Dietary supplement S-adenosyl-L-methionine (AdoMet) effects on plasma homocysteine levels in healthy human subjects: a double-blind, placebo-controlled, randomized clinical trial. J Altern Complement Med. 2009 May;15(5):523-9. doi: 10.1089/acm.2008.0402.
PMID: 19422296RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dietland Wahner-Roedler, M.D.
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 30, 2006
First Posted
January 31, 2006
Study Start
June 1, 2005
Primary Completion
April 1, 2006
Study Completion
May 1, 2006
Last Updated
January 6, 2012
Record last verified: 2012-01